Back to today’s briefing

Story perspectives

Breakthrough Radioisotope Targets Cancer Cells at Missouri

7/23/2025

24 2

Summary

Story summary

At the University of Missouri, researchers are making strides in cancer treatment with Terbium-161, a promising radioisotope designed to seek out and obliterate cancer cells. Under Heather Hennkens' leadership, this innovative study focuses on refining its production for radiopharmaceutical applications, potentially revolutionizing therapies by precisely targeting scattered cancer cells and decreasing dependence on imported isotopes.

1 of 1

Story summary

At the University of Missouri, researchers are making strides in cancer treatment with Terbium-161, a promising radioisotope designed to seek out and obliterate cancer cells. Under Heather Hennkens' leadership, this innovative study focuses on refining its production for radiopharmaceutical applications, potentially revolutionizing therapies by precisely targeting scattered cancer cells and decreasing dependence on imported isotopes.